CNS aquaporin-4 autoimmunity in children

Area of Science:

• Pediatric Neurology
• Neuroimmunology
• Autoimmune Diseases

Background:

• Autoantibodies targeting aquaporin-4 (AQP4) are established biomarkers for neuromyelitis optica (NMO) spectrum disorders in adults.
• These disorders typically affect the optic nerves and spinal cord.
• This study focuses on CNS AQP4 autoimmunity in the pediatric population.

Purpose of the Study:

• To characterize the neurological, serological, and radiographic features of CNS AQP4 autoimmunity in children.
• To understand the clinical presentation and disease course in pediatric patients.

Main Methods:

• Retrospective analysis of 88 children seropositive for NMO-IgG.
• Clinical data was available for 58 patients.
• Sera from 75 patients were tested for coexisting autoantibodies.

Main Results:

• The majority of patients (73%) were non-Caucasian.
• Optic neuritis (83%) and transverse myelitis (78%) were the most common initial attacks.
• Cerebral symptoms occurred in 45% of patients, and 68% had brain MRI abnormalities.
• Recurrent attacks were observed in 93% of patients, leading to significant disability, including visual impairment (54%) and motor deficits (44%).

Conclusions:

• Childhood AQP4 autoimmunity is a distinct, recurrent, and widespread inflammatory CNS disease.
• The condition presents with significant neurological deficits and requires ongoing management.
• Early diagnosis and intervention are crucial for improving outcomes in affected children.